Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation with Sorafenib

Patients with acute myeloid leukemia (AML) and internal tandem duplication of FMS-like tyrosine kinase receptor-3 gene (FLT3-ITD) mutation have poor prognoses and are often treated with allogeneic hematopoietic stem cell transplantation (HSCT). Sorafenib, an inhibitor of multiple kinases including F...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sharma, Manish, Ravandi, Farhad, Bayraktar, Ulas Darda, Chiattone, Alexandre, Bashir, Qaiser, Giralt, Sergio, Chen, Julianne, Qazilbash, Muzaffar, Kebriaei, Partow, Konopleva, Marina, Andreeff, Michael, Cortes, Jorge, McCue, Deborah, Kantarjian, Hagop, Champlin, Richard E., de Lima, Marcos
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4061979/
https://ncbi.nlm.nih.gov/pubmed/21767516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2011.07.011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados